tweenvest

Veraxa Biotech AG (NasdaqGM: VRXA)

Health Care · Biotechnology · DE

$1.11

-3.48% today · -89.4% 1Y

Public summary
A free snapshot of Veraxa Biotech AG, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Veraxa Biotech AG (NasdaqGM: VRXA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $156.96M and employs 8 people.

Over the last twelve months the share price has lost 89.4%, trading between 0.95 and 27.36.

Tweenvest scores Veraxa Biotech AG across four factors: quality 34/100, value 63/100. Its strongest factor is value.

VRXA price history

Nov 21, 2025 · 10.51Weekly closes 0.95 – 20.00Nov 13, 2026 · 1.11

Key figures

Market cap
$156.96M
Revenue (TTM)
$29.54K
P/E
-1.96
EPS
-5.80
Dividend yield
—
Beta (5Y)
0.22
52-week high
$27.36
52-week low
$0.95
Avg volume (3M)
—
Shares outstanding
141.41M
Employees
8
Next earnings
—

About Veraxa Biotech AG

Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company was founded in 2021 and is based in Heidelberg, Germany.

ISIN
CH1476899161
Founded
2021
Listed since
Jun 9, 2026
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
Invivyd, Inc.NasdaqGM: IVVD$158.96M$0.54-7.63%
Anbio BiotechnologyNasdaqGM: NNNN$158.01M$3.60-1.37%
Uwell Biopharma, Inc.TPEX: 7902$157.55MNT$25.85+1.37%
Zentalis Pharmaceuticals, Inc.NasdaqGM: ZNTL$157.23M$1.60-5.88%
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.SEHK: 1541$155.75MHK$2.85-1.22%
Fate Therapeutics, Inc.NasdaqGM: FATE$155.61M$1.28-4.48%
ProQR Therapeutics N.V.NasdaqCM: PRQR$155.46M$1.10-4.35%
HLB Therapeutics Co.,Ltd.KOSDAQ: A115450$153.96M₩2,335.00-2.30%

Browse every Biotechnology company →